Nattokinase-The Nemesis of Cardiovascular And Cerebrovascular Diseases
In 1996, the National Academy of Medical Sciences of South Korea: Natto products are 89% effective for cardiovascular and cerebrovascular patients. The 300,000 clinical observations completed in South Korea have pushed the theoretical research and clinical application of natto to a new level. The test population included patients with thrombosis, paralysis, numbness of limbs, acute myocardial infarction, speech disturbance, headache, dizziness, weakness, hypertension, fatty liver, myocardial hypertrophy, arteriosclerosis, hyperlipidemia, angina pectoris, coronary heart disease, etc. Clinical shows: the total effective rate of natto extract for cardiovascular and cerebrovascular patients is 89.29%, and the condition of most patients has improved very well. During the treatment, the condition of the disease has not changed only 0.09%.
In 2000, the US FDA: fully affirmed the preventive and therapeutic effects of natto on heart disease. The US Federal Food and Drug Administration (FDA) fully affirmed the effects of nattokinase on the prevention and rehabilitation of heart disease. The two doctors Martini Konhei, an American expert on cardiovascular and cerebrovascular diseases, said that in their lifetime research, nattokinase is the most effective thrombolytic agent newly developed for the prevention and treatment of cardiovascular and cerebrovascular and related diseases, and it is safe and non-toxic. toxic side effect.
In 2001, Chinese scientist Yuan Shuyun divided 70 Kunming mice into 7 groups for experiments and tested the blood lipid-lowering effect of natto extract. The results of the experiment were surprising. Nattokinase has a magical blood-lipid-lowering effect.